Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0VI9P
|
||||
| Former ID |
DIB000213
|
||||
| Drug Name |
OPN-305
|
||||
| Synonyms |
OPN-301; TLR-specific mAbs (inflammatory diseases), Opsona; Toll-like receptor specific monoclonal antibodies (inflammatory diseases), Opsona
|
||||
| Drug Type |
Antibody
|
||||
| Indication | Myelodysplastic syndrome [ICD9: 238.7; ICD10:D46] | Phase 2 | [524216] | ||
| Company |
Opsona therapeutics
|
||||
| Target and Pathway | |||||
| Target(s) | Toll-like receptor 2 | Target Info | [531811] | ||
| KEGG Pathway | Phagosome | ||||
| PI3K-Akt signaling pathway | |||||
| Toll-like receptor signaling pathway | |||||
| Legionellosis | |||||
| Leishmaniasis | |||||
| Chagas disease (American trypanosomiasis) | |||||
| Malaria | |||||
| Toxoplasmosis | |||||
| Amoebiasis | |||||
| Tuberculosis | |||||
| Hepatitis B | |||||
| Measles | |||||
| Herpes simplex infection | |||||
| Proteoglycans in cancer | |||||
| Inflammatory bowel disease (IBD) | |||||
| Rheumatoid arthritis | |||||
| NetPath Pathway | IL4 Signaling Pathway | ||||
| TCR Signaling Pathway | |||||
| PANTHER Pathway | Toll receptor signaling pathway | ||||
| Pathway Interaction Database | Endogenous TLR signaling | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.